Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Mar 2026 for Indivior Pharmaceuticals, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ryan Preblick: trading record in brief
Ryan Preblick discloses dealings in Indivior Pharmaceuticals, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 10 February 2026 to 14 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 17 March 2026 came the latest disclosure, a share grant for €77k in Indivior Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ryan Preblick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
6,302 sharesCommon StockSEC:0002014866-26-000008:0
1 of 1 declaration
